Medical Injectable Drug Program Changes in the New Year
Summary
Effective January 1, 2027, Highmark is adding 13 new drugs to its Medical Injectable Drug Program and adjusting reimbursement rates to align with average selling price (ASP) or average wholesale price (AWP) for drugs without an ASP. Billing teams must update their systems to recognize the new HCPCS codes and apply the corrected reimbursement methodology for these injectable medications.
Get alerts when payers change rules like this one
We check Highmark and other payers every day and email you when a change matches your specialty and state.